Biostem Technologies Inc.

01/08/2025 | Press release | Distributed by Public on 01/08/2025 06:16

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Biostem Technologies Inc. published this content on January 08, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 08, 2025 at 12:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]